• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Bacteria hijack latent phage of competitor

Bioengineer by Bioengineer
September 6, 2025
in Biology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Biochemists discover highly selective phage activation based on signal molecule

This targeted control of phages provides entirely new biotechnological and therapeutic approaches, e.g. for phage therapies. The results produced in the context of an ERC grant have been published in the Journal of the American Chemical Society.

Warfare between microbes

“We already know that phages decisively influence the population dynamics of bacteria and that microorganisms compete by using chemical weapons,” says Thomas Böttcher, Professor of Microbial Biochemistry of the Faculty of Chemistry and the Centre of Microbiology and Environmental Systems Science. “We now wanted to investigate whether, in the complex microbial ecosystems, there are also microbes that specifically activate phages in order to use them against their competitors.”

Indeed, the researchers could show that the bacterium Pseudomonas aeruginosa produces large amounts of a signal molecule that triggers the conversion of a phage, residing in a strain of the species Staphylococcus aureus, from a quiet companion into a deadly parasite.

Highly selective phage activation

“We were completely surprised to find that the chemical compound pyocyanin, which we were able to isolate and synthesise, only specifically activated one of several phages of Staphylococcus aureus. Pyocyanin is therefore a highly selective agent,” says co-author Magdalena Jancheva.

The drug mitomycin C induces DNA damage in bacterial cells and causes phages to leave their dying host, but according to Thomas Böttcher, “it activates all phages in the bacteria in a non-selective manner”. The researchers also observed that pyocyanin releases even more phages in Staphylococcus aureus than mitomycin C, pyocyanin therefore had an “remarkably strong effect”.

Discovery provides new perspectives

The bacterial species Pseudomonas aeruginosa and Staphylococcus aureus occupy the same ecological niche in the human body. As pathogens, they frequently occur in the lungs of patients with cystic fibrosis, a congenital metabolic disease. Staphylococcus bacteria dominate at a young age, while Pseudomonas bacteria become more prevalent with increasing age.

The current study demonstrates the efficiency of activation of latent phages by chemical signaling agents in the battle for space and resources between bacterial strains. It provides the first evidence that chemical signaling agents can exhibit selectivity for specific phages in a polylysogenic bacterial strain. Here, the activated phage (phiMBL3) revealed a previously unknown molecular switch through which the signaling agent acts.

###

Publication in “JACS – Journal of the American Chemical Society“:
A Metabolite of Pseudomonas Triggers Prophage-Selective Lysogenic to Lytic Conversion in Staphylococcus aureus. Magdalena Jancheva & Thomas Böttcher, in: Journal of the American Chemical Society 2021, DOI: https://doi.org/10.1021/jacs.1c01275

Media Contact
Dr. Thomas Böttcher
[email protected]

Related Journal Article

http://dx.doi.org/10.1021/jacs.1c01275

Tags: BiologyCell BiologyMicrobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Auranofin’s Anti-Leishmanial Effects: Lab and Animal Studies

September 12, 2025
blank

Fungal Effector Undermines Maize Immunity by Targeting ZmLecRK1

September 12, 2025

Hope for Sahara Killifish’s Rediscovery in Algeria!

September 12, 2025

Dihuang Yinzi Boosts Cognition, Fights Ferroptosis in Mice

September 12, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    64 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling Defect Dynamics in Zn-Doped CuO

Gal-9 on Leukemia Stem Cells Predicts Prognosis

Auranofin’s Anti-Leishmanial Effects: Lab and Animal Studies

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.